Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the benefit of bivalirudin in combination with
clopidogrel with provisional GPIIb/IIIa inhibitor use, in reducing the bleeding complications
associated with early invasive management of patients presenting with an ST Elevation
Myocardial Infarction (STEMI) and undergoing primary PCI, while providing similar rates of
ischemic events when compared to published results of relevant trials.